International Study With Nexavar About Safety and Efficacy in Carcinoma Hepatocellular Therapy (HCC)
Phase of Trial: Phase IV
Latest Information Update: 11 Jul 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms INSIGHT
- Sponsors Bayer
- 11 Jul 2017 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research.
- 24 Sep 2014 According to a Bayer HealthCare media release, results from this trial will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress.
- 13 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.